Notice: Users may be experiencing issues with displaying some pages on stanfordhealthcare.org. We are working closely with our technical teams to resolve the issue as quickly as possible. Thank you for your patience.
 

Learn about the flu shot, COVID-19 vaccine, and our masking policy »

Stanford Health Care

NCCN Guidelines Insights: Squamous Cell Skin Cancer, Version 1.2022. Journal of the National Comprehensive Cancer Network : JNCCN Schmults, C. D., Blitzblau, R., Aasi, S. Z., Alam, M., Andersen, J. S., Baumann, B. C., Bordeaux, J., Chen, P., Chin, R., Contreras, C. M., DiMaio, D., Donigan, J. M., Farma, J. M., Ghosh, K., Grekin, R. C., Harms, K., Ho, A. L., Holder, A., Lukens, J. N., Medina, T., Nehal, K. S., Nghiem, P., Park, S., Patel, T., Puzanov, I., Scott, J., Sekulic, A., Shaha, A. R., Srivastava, D., Stebbins, W., Thomas, V., Xu, Y. G., McCullough, B., Dwyer, M. A., Nguyen, M. Q. 1800; 19 (12): 1382-1394

Abstract

The NCCN Guidelines for Squamous Cell Skin Cancer provide recommendations for diagnostic workup, clinical stage, and treatment options for patients with cutaneous squamous cell carcinoma. The NCCN panel meets annually to discuss updates to the guidelines based on comments from panel members and the Institutional Review, as well as submissions from within NCCN and external organizations. These NCCN Guidelines Insights focus on the introduction of a new surgical recommendation terminology (peripheral and deep en face margin assessment), as well as recent updates on topical prophylaxis, immunotherapy for regional and metastatic disease, and radiation therapy.

View details for DOI 10.6004/jnccn.2021.0059

View details for PubMedID 34902824